Cargando…

Post-Prandial Lipid Levels for Assessing Target Goal Achievement in Type 2 Diabetic Patients Taking Statin

It is inconvenient to perform serum lipid analysis in fasting state in diabetic patients with drug treatment. In patients with statin treatment and Asian diet, it has not been clearly known whether non-fasting values could be used for the clinical decision making in diabetic patients. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Mikyung, Suk, Jihye, Kim, Hyunjung, Jung, Hyesuk, Kim, Taeik, Park, Jeonghyun
Formato: Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826752/
https://www.ncbi.nlm.nih.gov/pubmed/20191037
http://dx.doi.org/10.3346/jkms.2010.25.3.387
_version_ 1782177886636081152
author Kim, Mikyung
Suk, Jihye
Kim, Hyunjung
Jung, Hyesuk
Kim, Taeik
Park, Jeonghyun
author_facet Kim, Mikyung
Suk, Jihye
Kim, Hyunjung
Jung, Hyesuk
Kim, Taeik
Park, Jeonghyun
author_sort Kim, Mikyung
collection PubMed
description It is inconvenient to perform serum lipid analysis in fasting state in diabetic patients with drug treatment. In patients with statin treatment and Asian diet, it has not been clearly known whether non-fasting values could be used for the clinical decision making in diabetic patients. In this study, fasting and post-prandial plasma lipid profiles of hospitalized type 2 diabetic patients taking statin, were measured in whom standard diabetic breakfast in traditional Korean style were provided. In repeated-measures ANOVA, there were no significant differences among fasting, post-prandial 2 and 4 hr low-density lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol values. When compared to fasting levels, both post-prandial 2 hr and 4 hr LDL cholesterol levels were misclassified as not achieved target goal only in 4% of patients. Post-prandial HDL cholesterol matched with fasting values in women, without exception. In conclusion, the fasting and post-prandial LDL and HDL cholesterol levels are not significantly different each other and can be used in the assessment of achieving target goal in type 2 diabetes taking statin after Korean diet.
format Text
id pubmed-2826752
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher The Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-28267522010-03-01 Post-Prandial Lipid Levels for Assessing Target Goal Achievement in Type 2 Diabetic Patients Taking Statin Kim, Mikyung Suk, Jihye Kim, Hyunjung Jung, Hyesuk Kim, Taeik Park, Jeonghyun J Korean Med Sci Original Article It is inconvenient to perform serum lipid analysis in fasting state in diabetic patients with drug treatment. In patients with statin treatment and Asian diet, it has not been clearly known whether non-fasting values could be used for the clinical decision making in diabetic patients. In this study, fasting and post-prandial plasma lipid profiles of hospitalized type 2 diabetic patients taking statin, were measured in whom standard diabetic breakfast in traditional Korean style were provided. In repeated-measures ANOVA, there were no significant differences among fasting, post-prandial 2 and 4 hr low-density lipoprotein (LDL) and high density lipoprotein (HDL) cholesterol values. When compared to fasting levels, both post-prandial 2 hr and 4 hr LDL cholesterol levels were misclassified as not achieved target goal only in 4% of patients. Post-prandial HDL cholesterol matched with fasting values in women, without exception. In conclusion, the fasting and post-prandial LDL and HDL cholesterol levels are not significantly different each other and can be used in the assessment of achieving target goal in type 2 diabetes taking statin after Korean diet. The Korean Academy of Medical Sciences 2010-03 2010-02-17 /pmc/articles/PMC2826752/ /pubmed/20191037 http://dx.doi.org/10.3346/jkms.2010.25.3.387 Text en © 2010 The Korean Academy of Medical Sciences. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Kim, Mikyung
Suk, Jihye
Kim, Hyunjung
Jung, Hyesuk
Kim, Taeik
Park, Jeonghyun
Post-Prandial Lipid Levels for Assessing Target Goal Achievement in Type 2 Diabetic Patients Taking Statin
title Post-Prandial Lipid Levels for Assessing Target Goal Achievement in Type 2 Diabetic Patients Taking Statin
title_full Post-Prandial Lipid Levels for Assessing Target Goal Achievement in Type 2 Diabetic Patients Taking Statin
title_fullStr Post-Prandial Lipid Levels for Assessing Target Goal Achievement in Type 2 Diabetic Patients Taking Statin
title_full_unstemmed Post-Prandial Lipid Levels for Assessing Target Goal Achievement in Type 2 Diabetic Patients Taking Statin
title_short Post-Prandial Lipid Levels for Assessing Target Goal Achievement in Type 2 Diabetic Patients Taking Statin
title_sort post-prandial lipid levels for assessing target goal achievement in type 2 diabetic patients taking statin
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826752/
https://www.ncbi.nlm.nih.gov/pubmed/20191037
http://dx.doi.org/10.3346/jkms.2010.25.3.387
work_keys_str_mv AT kimmikyung postprandiallipidlevelsforassessingtargetgoalachievementintype2diabeticpatientstakingstatin
AT sukjihye postprandiallipidlevelsforassessingtargetgoalachievementintype2diabeticpatientstakingstatin
AT kimhyunjung postprandiallipidlevelsforassessingtargetgoalachievementintype2diabeticpatientstakingstatin
AT junghyesuk postprandiallipidlevelsforassessingtargetgoalachievementintype2diabeticpatientstakingstatin
AT kimtaeik postprandiallipidlevelsforassessingtargetgoalachievementintype2diabeticpatientstakingstatin
AT parkjeonghyun postprandiallipidlevelsforassessingtargetgoalachievementintype2diabeticpatientstakingstatin